IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8 + T cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8
+
T cells
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-20
DOI
10.1111/imm.13404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The harsh microenvironment in early breast cancer selects for a Warburg phenotype
- (2021) Mehdi Damaghi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
- (2021) Michal A. Stanczak et al. Nature Communications
- IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii
- (2021) Joseph T Clark et al. eLife
- Metformin Modulates T Cell Function and Alleviates Liver Injury Through Bioenergetic Regulation in Viral Hepatitis
- (2021) Lanman Xu et al. Frontiers in Immunology
- p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells
- (2020) Tsvetana Petrova et al. Scientific Reports
- Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A–Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection
- (2020) Yuejin Liang et al. JOURNAL OF IMMUNOLOGY
- Metabolic signaling in T cells
- (2020) Justin A. Shyer et al. CELL RESEARCH
- A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection from Myocardial Infarction
- (2020) Ni Xia et al. CIRCULATION
- Lung megakaryocytes are immune modulatory cells
- (2020) Daphne N. Pariser et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars
- (2019) Gemma Sangüesa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion
- (2019) Aikaterini Hatzioannou et al. NATURE IMMUNOLOGY
- Role of mTOR in Glucose and Lipid Metabolism
- (2018) Zhuo Mao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
- (2018) Ashley V. Menk et al. Cell Reports
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease
- (2017) Sachiko Furukawa et al. Scientific Reports
- A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection
- (2017) Panpan Yi et al. Scientific Reports
- The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
- (2016) Vikram Mehraj et al. AIDS
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
- (2016) Michael D. Buck et al. CELL
- The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
- (2016) Vikram Mehraj et al. EBioMedicine
- Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells
- (2016) Violette Gautier et al. Scientific Reports
- The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
- (2015) D. K. Reichenbach et al. BLOOD
- IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice
- (2015) Yuejin Liang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-infiltrating, interleukin-33-producing effector-memory CD8+T cells in resected hepatocellular carcinoma prolong patient survival
- (2015) Stefan M. Brunner et al. HEPATOLOGY
- The Interleukin-33-p38 Kinase Axis Confers Memory T Helper 2 Cell Pathogenicity in the Airway
- (2015) Yusuke Endo et al. IMMUNITY
- mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
- (2015) Kristen N. Pollizzi et al. JOURNAL OF CLINICAL INVESTIGATION
- T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
- (2015) Claudia Baumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR: A gate to NK cell maturation and activation
- (2014) Antoine Marçais et al. CELL CYCLE
- The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
- (2014) Andrew N. Macintyre et al. Cell Metabolism
- IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
- (2014) Dong Li et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- Excess IL-1 Signaling Enhances the Development of Th17 Cells by Downregulating TGF- -Induced Foxp3 Expression
- (2014) S. Ikeda et al. JOURNAL OF IMMUNOLOGY
- The alarmin IL-33 promotes regulatory T-cell function in the intestine
- (2014) Chris Schiering et al. NATURE
- Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in CD8 versus CD4 T Cells
- (2014) Yilin Cao et al. PLoS One
- Metabolic Regulation of T Lymphocytes
- (2013) Nancie J. MacIver et al. Annual Review of Immunology
- Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
- (2013) Tamar Mchedlidze et al. IMMUNITY
- IL-33 Induces Nuocytes and Modulates Liver Injury in Viral Hepatitis
- (2013) Y. Liang et al. JOURNAL OF IMMUNOLOGY
- Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation
- (2012) Yeon-Sook Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin
- (2012) Robert J. Salmond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion
- (2012) I. G. Luzina et al. JOURNAL OF IMMUNOLOGY
- The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
- (2012) W. V. Bonilla et al. SCIENCE
- Interleukin-33 and the function of innate lymphoid cells
- (2012) Ananda S. Mirchandani et al. TRENDS IN IMMUNOLOGY
- IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells
- (2011) Qianting Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation
- (2011) Jennifer Louten et al. INTERNATIONAL IMMUNOLOGY
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Tregcells
- (2011) Lewis Z. Shi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
- (2010) Jonathan D. Powell et al. IMMUNITY
- IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
- (2008) M. D. Smithgall et al. INTERNATIONAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started